ScholarIQanswers from OpenAlex
Instituto Médico DAMIC
InstitutionResearch output, impact & collaborations
Instituto Médico DAMIC is a institution indexed in ScholarIQ from OpenAlex.
What is known about Instituto Médico DAMIC?
ScholarIQrecord summary
Instituto Médico DAMIC is a research organisation in Córdoba, AR. OpenAlex records 163 works and 11,689 citations for it.
How many works does Instituto Médico DAMIC have?
ScholarIQindexed works
Instituto Médico DAMIC has 163 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Instituto Médico DAMIC have?
ScholarIQcitation count
Instituto Médico DAMIC has 11,689 citations in the OpenAlex counts ScholarIQ stores.
What is the average h-index at Instituto Médico DAMIC?
ScholarIQavg h-index
Instituto Médico DAMIC has an average h-index of 27 in OpenAlex.
What is the ROR of Instituto Médico DAMIC?
ScholarIQror
The ROR for Instituto Médico DAMIC is on the source record.
What is the OpenAlex record for Instituto Médico DAMIC?
ScholarIQopenalex
The OpenAlex for Instituto Médico DAMIC is on the source record.
Who are the most-cited researchers behind Instituto Médico DAMIC?
ScholarIQtop researchers by citations
What are the most-cited papers on Instituto Médico DAMIC?
ScholarIQmost cited works
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M. Ridker, Brendan M. Everett, Tom Thurén, Jean MacFadyen, William H. Chang, Christie M. Ballantyne, Francisco Antônio Helfenstein Fonseca, José Carlos Nicolau, Wolfgang Köenig, Stefan D. Anker, John J.P. Kastelein, Jan H. Cornel, Prem Pais, Daniel Pella, Jacques Genest, Renata Cífková, Alberto Lorenzatti, Tamás Forster, Zhanna Kobalava, L Vida-Simiti, Marcus Flather, Hiroaki Shimokawa, Hisao Ogawa, Mikael Dellborg, Paulo R.F. Rossi, Roland P.T. Troquay, Peter Libby, Robert J. Glynn
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
Paul M. Ridker, Jean MacFadyen, Brendan M Everett, Peter Libby, Tom Thurén, Robert J. Glynn, Paul M. Ridker, Jean MacFadyen, Brendan M Everett, Peter Libby, Tom Thurén, Robert J. Glynn, John J.P. Kastelein, Wolfgang Köenig, Jacques Genest, Alberto Lorenzatti, George Varigos, Peter Siostrzonek, Peter Sinnaeve, Francisco Antônio Helfenstein Fonseca, José Carlos Nicolau, Nina Gotcheva, Yong Huo, Miguel Urina‐Triana, Davor Miličić, Renata Cífková, Riina Vettus, S.D. Anker, Athanasios Manolis, Fernando Wyss, Tamás Forster, Axel F. Sigurðsson, Prem Pais, Alessandro Fucili, Hisao Ogawa, Hiroaki Shimokawa, Irina Veze, Birutė Petrauskienė, Leon Salvador, Jan H. Cornel, Tor Ole Klemsdal, Félix Medina, Andrzej Budaj, L Vida-Simiti, Zhanna Kobalava, Petar Otašević, Daniel Pella, Mitja Lainščak, Ki‐Bae Seung, Patrick Commerford, Mikael Dellborg, Marc Y. Donath, Juey‐Jen Hwang, Hakan Kültürsay, Marcus Flather, Christie M. Ballantyne, Seth Bilazarian, William H. Chang, Cara East, Les B. Forgosh, Barry Harris, M Ligueros
How much of the research on Instituto Médico DAMIC is open access?
ScholarIQopen access share
100%OPEN ACCESS